WHMIS (7,12-Dimethylbenz(a)anthracene)

Workplace Hazardous Materials Information System

WHMIS 2015 classification - Note to reader
Update: 2014-11-14

  • Acute toxicity - oral - Category 41
  • Germ cell mutagenicity - Category 22 3 4
  • Acute toxicity - dermal - Not reviewed
  • Acute toxicity - inhalation - Not reviewed
  • Reproductive toxicity (lactation) - Effects on or via lactation : Not reviewed
  • Specific target organ toxicity - single exposure - Not reviewed

  • WHMIS 2015 pictogram : Exclamation mark

  • WHMIS 2015 pictogram : Health hazard


Harmful if swallowed (H302)
Suspected of causing genetic defects (H341)
Acute toxicity - dermal : Not available
Acute toxicity - inhalation : Not available
Effects on or via lactation : Not available
Specific target organ toxicity - single exposure : Not available

Ingredient disclosure

Comments: This classification comes from an automated conversion of the classification established under the Controlled Products Regulations. The complete classification under the Hazardous Products Regulations will be determined at a later date.


  • ▲1.  Yoshida, H. et Fukunishi, R., «Mammary tumor and leukemia in male sprague-dawley rats evoked by a series of intragastric administration of 7,12-dimethylbenz[a]anthracene.» Japanese journal of cancer research. Vol. 68, p. 237-239. (1977).
  • ▲2.  Shibuya, T. et Murota, T., «Mouse spot tests with dimethylbenz[a]anthracene with and without phenobarbital pretreatment.» Mutation Research. Vol. 141, p. 105-108. (1984).
  • ▲3.  Proudlock, R.J. et Allen, J.A., «Micronuclei and other nuclear anomalies induced in various organs by diethylnitrosamine and 7,12-dimethylbenz[a]anthracene..» Mutation Research. Vol. 174, p. 141-143. (1986).
  • ▲4.  Sudharsan Raj, A. et al., «Caffeic acid as an inhibitor of DMBA-induced chromosomal breakage in mice assessed by bone-marrow micronucleus test..» Mutation Research. Vol. 124, p. 247-253. (1983).

The [number] refers to the Information SST database of the CNESST Documentation Center.